Triiodothyronine Analog May Improve Outcomes for Patients With MCT8 Deficiency
Triac normalized T3 concentrations and improved measures of body weight and cardiovascular function in patients with monocarboxylate transporter 8 deficiency.
Thyroid
Annual Postoperative Ultrasound May Not Be Necessary in Low-Risk Thyroid Cancer
Serum tumor markers alone can provide reliable surveillance of patients who undergo total thyroidectomy for low- and intermediate-risk papillary thyroid carcinoma.
Estimates of Abnormal TSH Levels in Youth Hospitalized for Psychiatric Care
About 6 percent of psychiatrically hospitalized youth have abnormal thyroid-stimulating hormone measures.
No Difference in Levothyroxine Dose in Patients With vs Without Heart Failure
Maintenance dose of levothyroxine does not differ in patients with hypothyroidism with vs without heart failure.
Thyroid Dysfunction Common in Children Treated With Amiodarone
Children and young adults treated with amiodarone have a significant likelihood for thyroid dysfunction soon after treatment initiation.
Case Report: Severe Proximal Myopathy Can Be Secondary to Hypothyroidism, Hashimoto Thyroiditis
This case study illustrates that severe proximal myopathy can be secondary to hypothyroidism. It also emphasizes the importance of measuring thyroid function in patients with proximal weakness, myalgia, and a significantly raised creatine kinase.
Patient Preference for Levo-Triiodothyronine, Levothyroxine Combination Therapy vs Levothyroxine Alone
Researchers assessed patient preference for combination L-T3/L-T4 treatment vs L-T4 monotherapy.
Thyroid-Stimulating Hormone Reference Ranges for Extremely and Very Preterm Infants
At 3 to 4 weeks of life, when repeat newborn screening is often performed, median TSH levels ranged from 2.5 to 2.6 µIU/mL in both extremely and very preterm infants.
Maternal Thyroid Function in Early Pregnancy Affects Child Brain Morphology
The association of TSH with child brain morphology differed according to gestational age at evaluation of thyroid function.
Many Patients Perceive Lack of Choice in Receiving RAI for Thyroid Cancer
Many patients diagnosed with differentiated thyroid cancer perceive that they have no choice about receiving radioactive iodine.
Next post in News
